Investment Risks

Cassava Stock Plummets on $40M SEC Alzheimer’s Settlement

Cassava Sciences, a company renowned for its work on treating neurodegenerative diseases, faced a significant financial blow following a $40 million settlement with the Securities and Exchange Commission...

No posts to display